Prestige BioPharma Balance Sheet

Financials in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2019 - 2020
Cash & Equivalents	115,378	219,433	125,022	268,651	458,975	Upgrade
Short-Term Investments	58,334	3,058	176,390	25,584	-	Upgrade
Trading Asset Securities	-	-	-	9,035	377.68	Upgrade
Cash & Short-Term Investments	173,712	222,492	301,412	303,270	459,353	Upgrade
Cash Growth	-21.92%	-26.18%	-0.61%	-33.98%	849.10%	Upgrade
Accounts Receivable	607.07	391.6	132.72	-	-	Upgrade
Receivables	607.07	391.6	132.72	-	-	Upgrade
Inventory	26,995	18,103	7,146	2,157	-	Upgrade
Prepaid Expenses	1,641	2,733	2,731	-	-	Upgrade
Other Current Assets	7,049	6,632	53.44	6,139	584.08	Upgrade
Total Current Assets	210,004	250,352	311,476	311,566	459,937	Upgrade
Property, Plant & Equipment	341,657	327,062	310,438	38,342	6,437	Upgrade
Long-Term Investments	-	-	-	74,710	24,159	Upgrade
Goodwill	10,530	10,785	10,192	-	-	Upgrade
Other Intangible Assets	30,056	31,327	29,877	4,288	450.33	Upgrade
Long-Term Deferred Charges	152,882	91,643	78,843	61,024	108,573	Upgrade
Other Long-Term Assets	525.18	551.5	775.14	9,883	4,611	Upgrade
Total Assets	745,654	711,720	741,600	499,813	604,166	Upgrade
Accounts Payable	5,864	2,282	462.15	2,624	-	Upgrade
Accrued Expenses	4,872	5,975	6,150	4,923	3,552	Upgrade
Short-Term Debt	95,939	36,954	31,188	-	2,873	Upgrade
Current Portion of Long-Term Debt	14,083	10,891	31,176	-	-	Upgrade
Current Portion of Leases	1,018	950.81	1,682	1,593	1,326	Upgrade
Current Unearned Revenue	-	-	-	-	565	Upgrade
Other Current Liabilities	43,546	88,805	64,231	32,654	5,730	Upgrade
Total Current Liabilities	165,322	145,857	134,888	41,794	14,046	Upgrade
Long-Term Debt	32,498	40,247	50,190	-	-	Upgrade
Long-Term Leases	641.93	624.04	1,326	2,656	3,571	Upgrade
Long-Term Unearned Revenue	-	-	-	25,427	11,588	Upgrade
Long-Term Deferred Tax Liabilities	7,310	7,755	7,368	-	-	Upgrade
Other Long-Term Liabilities	31,572	1,734	1,593	0	-	Upgrade
Total Liabilities	237,343	196,219	195,365	69,877	29,206	Upgrade
Common Stock	713,096	730,340	690,175	679,713	594,072	Upgrade
Additional Paid-In Capital	-31,606	7,865	7,286	7,175	-	Upgrade
Retained Earnings	-266,271	-294,797	-246,151	-259,601	-27,954	Upgrade
Comprehensive Income & Other	-4,209	-4,321	-798.76	2,649	8,843	Upgrade
Total Common Equity	411,010	439,087	450,511	429,936	574,961	Upgrade
Minority Interest	97,301	76,414	95,724	-	-	Upgrade
Shareholders' Equity	508,311	515,502	546,235	429,936	574,961	Upgrade
Total Liabilities & Equity	745,654	711,720	741,600	499,813	604,166	Upgrade
Total Debt	144,179	89,667	115,561	4,249	7,771	Upgrade
Net Cash (Debt)	29,533	132,825	185,851	299,020	451,582	Upgrade
Net Cash Growth	-77.77%	-28.53%	-37.85%	-33.78%	892.04%	Upgrade
Net Cash Per Share	490.33	2215.00	3092.56	4975.70	8751.18	Upgrade
Filing Date Shares Outstanding	60.19	300.48	300.48	300.48	300.48	Upgrade
Total Common Shares Outstanding	60.19	300.48	300.48	300.48	300.48	Upgrade
Working Capital	44,682	104,494	176,588	269,771	445,890	Upgrade
Book Value Per Share	6828.29	1461.28	1499.30	1430.83	1913.47	Upgrade
Tangible Book Value	370,424	396,976	410,442	425,647	574,510	Upgrade
Tangible Book Value Per Share	6154.01	1321.13	1365.95	1416.55	1911.97	Upgrade
Land	27,332	27,704	26,567	12,055	-	Upgrade
Buildings	136,640	77,472	76,415	-	-	Upgrade
Machinery	79,512	72,427	51,848	10,175	3,455	Upgrade
Construction In Progress	110,263	152,876	169,147	15,415	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.